CrushSCI.com
Journal Selection & Manuscript Polishing Services
Molecular Oncology journal cover Medicine
Back to journal directory

Review Cycle Records

Molecular Oncology

Wiley SCIE OA
2026 Emerging Zone 22025 CAS Zone 22025 JCR Q2
125.8Average days
126.5Median days
2Fastest days
317Longest days
2282025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

115 days

Cancer cell‐intrinsic type 1 interferon: production, signaling, and outcomes within sex‐biased, female malignancies

AuthorsAshlyn Conant; Nora Badiner; Sharon Asariah; Kiera McGivney; Vishwa Shah; Tise Suzuki; Yevgeniya J. Ioffe; Juli J. Unternaehrer

Affiliations1. Division of Biochemistry, Department of Basic Sciences Loma Linda University CA USA; 2. Division of Gynecologic Oncology, Department of Gynecology and Obstetrics Loma Linda University CA USA; 3. Department of Biochemistry Whitworth University Country Homes WA USA

Source PDF DOI Publisher page
135 days

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

AuthorsAshlyn Conant; Tise Suzuki; Kiera McGivney; V. S. S. Abhinav Ayyadevara; Sharon Asariah; Jay Deng; Ethan Nyein; Jacqueline Coats; Gary Yu; Yevgeniya J. Ioffe; Christian Hurtz; Juli J. Unternaehrer

Affiliations1. Division of Biochemistry, Department of Basic Sciences Loma Linda University California USA; 2. Department of Biochemistry Whitworth University Spokane Washington USA; 3. Division of Cancer Sciences, Department of Basic Sciences Loma Linda University California USA; 4. Department of Biology University of Redlands California USA; 5. Department of Gynecology and Obstetrics Loma Linda University California USA; 6. Division of Gynecologic Oncology, Department of Gynecology and Obstetrics Loma Linda University California USA

Source PDF DOI Publisher page
51 days

Astrocyte heterogeneity in brain metastases

AuthorsCarolina Hernández‐Oliver; Neibla Priego; Manuel Valiente

Affiliations1. Brain Metastasis Group Spanish National Cancer Research Centre (CNIO) Madrid Spain

Source PDF DOI Publisher page
22 days

From tumor‐centric to ecosystem‐based hypotheses in brain tumor research and care

AuthorsJulie Gavard; Flavie Bénard; Eva Billat; Margaux Le Guyon; Victoria Maltret; Laura Merlet; Chloé Astrid Walter; Tony Avril; Eric Chevet

Affiliations1. CRCINA, CNRS, Inserm Nantes Université, Université Angers France; 2. Équipe Labellisée Ligue contre le Cancer Paris France; 3. Institut de Cancérologie de l'Ouest Saint Herblain France; 4. UMR1242 INSERM University of Rennes France; 5. Équipe Labellisée Fondation pour la Recherche Médicale Rennes France; 6. Comprehensive Cancer Center Eugène Marquis Rennes France

Source PDF DOI Publisher page
183 days

ZW4864 ‐mediated inhibition of the β‐catenin/ BCL9 / BCL9L complex reveals therapeutic potential in bladder cancer

AuthorsRoland Kotolloshi; Mandy Berndt‐Paetz; Eileen Lerner; Gregoire Najjar; Anca Azoitei; Krishna Pal Singh; Shailendra Kumar Gupta; Olaf Wolkenhauer; Cagatay Günes; Otmar Huber; Marc‐Oliver Grimm; Daniel Steinbach

Affiliations1. Department of Urology Jena University Hospital Germany; 2. Department of Urology University Medical Center Rostock Germany; 3. UroFors Consortium (Natural Scientists in Urological Research), German Society of Urology Düsseldorf Germany; 4. Department of Urology Leipzig University Germany; 5. Department of Urology Ulm University Hospital Germany; 6. Department of Systems Biology & Bioinformatics, Institute of Computer Science University of Rostock Germany; 7. Clinic and Policlinic for Dermatology, Venereology and Allergology University Medical Center Rostock Germany; 8. German Study Group of Bladder Cancer (DFBK e.V.), Munich Germany; 9. Department of Biochemistry II Jena University Hospital Germany

Source PDF DOI Publisher page
176 days

Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis

AuthorsDeepa Bisht; Sameer Gupta; Amrita Chaurasia; Manisha Sachan

Affiliations1. Department of Biotechnology Motilal Nehru National Institute of Technology Allahabad Uttar Pradesh India; 2. Department of Surgical Oncology King George Medical University Lucknow India; 3. Department of Gynaecology and Obstetrics Motilal Nehru Medical College Allahabad India

Source PDF DOI Publisher page
183 days

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

AuthorsYoussra Salhi; Stavros Makrodimitris; Sandra van Wilpe; Iris te Paske; Vanja de Weerd; Corine M. Beaufort; Hans M. Westgeest; Jens Voortman; Maureen J. B. Aarts; Maud Rijnders; Astrid A. M. van der Veldt; Ronald de Wit; Niven Mehra; Saskia M. Wilting; Debbie G. J. Robbrecht

Affiliations1. Department of Medical Oncology Erasmus MC Cancer Institute Rotterdam The Netherlands; 2. Department of Medical Oncology Radboud University Medical Center Nijmegen The Netherlands; 3. Department of Medical Oncology Amphia Hospital Breda The Netherlands; 4. Department of Medical Oncology Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam The Netherlands; 5. Department of Medical Oncology, GROW Research Institute for Oncology and Reproduction Maastricht University Medical Center+ The Netherlands; 6. Department of Internal Medicine Franciscus Gasthuis & Vlietland Rotterdam The Netherlands; 7. Department of Radiology and Nuclear Medicine Erasmus MC Cancer Institute Rotterdam The Netherlands

Source PDF DOI Publisher page
2 days

Weakening the nuclear envelope: Lamin B receptor in melanoma metastasis

AuthorsFrancesca Lorenzini; Maria Caterina Mione

Affiliations1. Experimental Cancer Biology, Department of Cellular, Computational and Integrative Biology (CIBIO) University of Trento Italy

Source PDF DOI Publisher page
92 days

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

AuthorsMarcin Grochowski; Liudmyla Dolinchuk; Michał Jerzak; Albert Gandurski; Tomasz Grochowski; Weronika Wojtyś; Maciej Zadrożny; Wojciech Kaźmierczak; Małgorzata Lenarcik; Marta Matejak‐Górska; Radosław Samsel; Tomasz Olesiński; Dawid Walerych

Affiliations1. Mossakowski Medical Research Institute PAS Warsaw Poland; 2. Doctoral School of Translational Medicine Center for Postgraduate Medical Education Warsaw Poland; 3. Medical University of Warsaw Poland; 4. Maria Skłodowska‐Curie National Research Institute of Oncology Warsaw Poland; 5. Clinical Department of Gastroenterological Surgery and Transplantology National Medical Institute of the Ministry of the Interior and Administration Warsaw Poland

Source PDF DOI Publisher page
317 days

Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma

AuthorsKonrad Stawiski; Júlia Perera‐Bel; Alejo Rodriguez‐Vida; Nuria Juanpere; Jihyun Lee; Daniel E. Michaud; Jennifer L. Guerriero; Kent W. Mouw; Aristotelis Bamias; Filipe L. F. Carvalho; Joaquim Bellmunt

Affiliations1. Department of Radiation Oncology Dana Farber Cancer Institute Boston MA USA; 2. Department of Biostatistics and Translational Medicine Medical University of Lodz Poland; 3. PSMAR Hospital del Mar Medical Research Institute (IMIM) Barcelona Spain; 4. Medical Oncology Department Hospital del Mar, CIBERONC Barcelona Spain; 5. Department of Urology Brigham and Women's Hospital Boston MA USA; 6. Division of Breast Surgery, Department of Surgery Brigham and Women's Hospital Boston MA USA; 7. Harvard Medical School Boston MA USA; 8. Department of Radiation Oncology Brigham and Women's Hospital Boston MA USA; 9. National and Kapodistrian University of Athens Greece; 10. Department of Medical Oncology Dana Farber Cancer Institute Boston MA USA

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.